IONS · Forms 3, 4, 5
Insider trades at IONIS PHARMACEUTICALS INC
1 insider bought $1.1M of IONIS PHARMACEUTICALS INC stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for IONIS PHARMACEUTICALS INC (IONS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| C Frank Bennett | EVP, Chief Scientific Officer | Other | 110 | $51.31 | $6K | Form 4 | |
| Patrick R. O'Neil | EVP CLO & General Counsel | Other | 63 | $51.31 | $3K | Form 4 | |
| Brett P Monia | Chief Executive Officer | Other | 98 | $51.31 | $5K | Form 4 | |
| Brian Birchler | EVP, Corp and Development Ops | Other | 58 | $51.31 | $3K | Form 4 | |
| Michael R Hayden | Director | Buy | 5,000 | $51.60 | $258K | Form 4 | |
| Michael R Hayden | Director | Buy | 15,000 | $53.38 | $801K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.